17 results
6-K
EX-99.3
PRQR
ProQR Therapeutics N.V
1 Jun 22
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates
7:05am
until its acquisition by Merck & Co. Ms. Lawton is past President and Chair of the Board of Regulatory Affairs Professional Society and past FDA Advisory
6-K
EX-99.2
PRQR
ProQR Therapeutics N.V
4 Nov 21
Current report (foreign)
7:30am
presented in an oral presentation at the European Society of Retina Specialists (EURETINA) virtual congress.
Earlier stage clinical pipeline
6-K
EX-99.2
e8hb y47qcz
7 Aug 19
Current report (foreign)
7:55am
6-K
EX-99.1
yux7cty fdld8vyxxz
8 May 19
Current report (foreign)
4:13pm
6-K
EX-99.1
fn70g7
27 Feb 19
ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
8:27am
6-K
EX-99.2
pfizku 8s
7 Nov 18
PROQR THERAPEUTICSÂ N.V. Index to Unaudited Condensed Consolidated Financial Statements
4:40pm
6-K
EX-99.2
ebupv
8 Aug 18
PROQR THERAPEUTICSÂ N.V. Index to Unaudited Condensed Consolidated Financial Statements
4:37pm
20-F
7hx7x 6xt6
22 Apr 15
Annual report (foreign)
12:00am
- Prev
- 1
- Next